Amgen reported $36.8B in revenue and $7.7B in net income for its most recent four quarters. The company's net margin is 21.0%. Amgen's consistent revenue and earnings growth demonstrate the company's ability to effectively manage its operations. This suggests it can continue delivering solid financial performance. Amgen has $9.1B in cash on its balance sheet and $54.6B in debt, providing it financial flexibility. The company generated $8.1B in free cash flow over the past four quarters, demonstrating its ability to convert earnings into cash. Amgen's steady free cash flow generation and financial strength bolster its ability to invest in growth initiatives, make strategic acquisitions, and return capital to shareholders - all of which can support the stock's long-term appreciation. Given Amgen's favorable financial profile, including its revenue and earnings growth and solid cash flow, I believe the stock is an attractive long-term investment option. The company's consistent performance makes it well-positioned to continue delivering value.

1 Reply

Research these companies